Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지

Streptococcal Toxic Shock Syndrome Occurred during Postoperative Radiotherapy in a Cancer Patient with Preexisting Lymphedema and Chronic Illness -Case Report-

수술 후 림프부종과 만성질환을 동반한 종양 환자에서 방사선치료 기간 동안 발생한 연쇄구균독소충격증후군 예

  • Jang, Ji-Young (Departments of Radiation Oncology, Chosun University College of Medicine) ;
  • Oh, Yoon-Kyeong (Departments of Radiation Oncology, Chosun University College of Medicine) ;
  • Kim, Dong-Min (Departments of Internal Medicine, Chosun University College of Medicine)
  • 장지영 (조선대학교 의과대학 방사선종양학교실) ;
  • 오윤경 (조선대학교 의과대학 방사선종양학교실) ;
  • 김동민 (조선대학교 의과대학 내과학교실)
  • Published : 2006.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

A case is reported of a man with malignant fibrous histiocytoma (MFH) in right thigh who developed streptococcal toxic shock syndrome (STSS) during postoperative radiotherapy. Before radiotherapy, a patient complained wax and wane lymphedema following wide excision of tumor mass which was confirmed as MFH. He took some nonsteroidal antiinflammatory drug (NSAID) for about one month. He suffered preexisting hepatitis C virus (HCV) infection, diabetes and well-controlled hypertension. The patient received conventional radiotherapy to right thigh with a total dose of 32.4 Gy at 1.8 Gy per day. At last radiotherapy fraction, cutaneous erythematous inflammation was suddenly developed at his affected thigh. At that time, he also complained of oliguria, fever and chills. The patient was consulted to internal medicine for adequate evaluation and management. The patient was diagnosed as suggested septic shock and admitted without delay. At admission, he showed hypotension, oliguria, constipation, abnormal renal and liver function. As a result of blood culture, Streptococcus pyogenes was detected. The patient was diagnosed to STSS. He was treated with adequate intravenous antibiotics and fluid support. STSS is one of oncologic emergencies and requires immediate medical intervention to prevent loss of life. In this patient, underlying HCV infection, postoperative lymphedema, prolonged NSAID medication, and radiotherapy may have been multiple precipitating factors of STSS.

67세 남자환자가 하지의 악성섬유조직구종으로 진단받고 광범위 절제술 후 방사선치료를 받는 동안 연쇄구균독소충격증후군이 발생하여 그 예를 소개하고자 한다. 환자는 수술 후 증감하는 부종이 있어 약 1개월간 비스테로이드소염제를 복용하였다. 환자는 C형 간염보균자였으며, 당뇨, 고혈압의 과거력이 있었다. 환자는 수술 후 방사선치료를 계획하여, 주 5회 조사하여 32.4 Gy를 치료받았다. 이틀간의 주말 치료중단이후 갑자기 방사선치료 받은 우측 대퇴부에 홍반성 염증이 발생하였고, 열, 오한, 소변감소증이 동반되었다. 환자는 즉시 감염내과에 의뢰되었고, 독소충격증후군이 의심되어 즉시 입원하였다. 입원당시 환자는 저혈압, 소변감소증, 변비, 비정상적인 신기능 및 간기능 소견을 보였다. 환자의 혈액 배양 결과 스트렙토콕쿠스 피오게네스균(Streptococcus pyogenes)이 검출되었다. 환자는 연쇄구균독소충격증후군으로 진단받고 적절한 항생제치료와 수액공급을 받았다. 연쇄구균독소충격증후군은 생명을 위협하는 종양학적 응급상황으로 즉각적인 처치가 필요하다. 본 예의 환자는 C형 간염보균, 수술 후 증감되는 부종, 지속적인 비스테로이드소염제 복용과 방사선치료가 연쇄구균독소충격증후군을 일으킨 인자들로 생각되어진다.

Keywords

References

  1. Rockson SG. Lymphedema. Am J Med 2001;110:288-295 https://doi.org/10.1016/S0002-9343(00)00727-0
  2. Rescigno J, McCormick B, Brown AE, Myskowski PL. Breast cellulitis after conservative surgery and radiotherapy. Int Radiat Oncol Biol Physics 1994;29:163-166 https://doi.org/10.1016/0360-3016(94)90239-9
  3. Dankert J, Bourna J. Recurrent acute leg cellulitis after hysterectomy with pelvic lymphadenectomy. Br J Obstet Gynecol 1987;94:788-790 https://doi.org/10.1111/j.1471-0528.1987.tb03728.x
  4. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infection associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl Med 1989;321:1-7 https://doi.org/10.1056/NEJM198907063210101
  5. The working group on severe streptococcal infections. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 1993;269:390-391 https://doi.org/10.1001/jama.269.3.390
  6. Dele DH, Allison M, Benjamin S, et al. Invasive group A streptococcal infections in Ontario, Canada. NEJM 1996;335: 547-554 https://doi.org/10.1056/NEJM199608223350803
  7. Hasegawa T, Hashikawa S, Nakamura T, Torii K, Ohta M. Factors determining prognosis in streptococcal toxic shock- like syndrome: results of a nationwide investigation in Japan. Microbes Infect 2004;6:1073-1077 https://doi.org/10.1016/j.micinf.2004.06.001
  8. EL-Serag HB, Anand B, Richardson P, Rabeneck R. Association between hepatitis C infection and other infectious diseases: a case for targeted screening? AJG 2003;98:167-174 https://doi.org/10.1111/j.1572-0241.2003.07176.x
  9. Henkei JS, Armstrong D, Blevins A, Moody MD. Group A beta-hemolytic streptococcus bacteremia in a cancer hospital. JAMA 1970;211:983-986 https://doi.org/10.1001/jama.211.6.983
  10. Lentnek AL, Giger O, O'Rourke E. Group A beta-hemolytic streptococcal bacteremia and intravenous substance abuse. Arch Intern Med 1990;150:89-93 https://doi.org/10.1001/archinte.150.1.89
  11. Schummer W, Schummer C. Nonsteroidal anti-unflammatory drugs and streptococcal toxic shock syndrome. Intensive Care Med 2002;28:1194
  12. Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance progression of bacterial infection to toxic shock syndrome? Clni Infect Dis 1995;21:977-980 https://doi.org/10.1093/clinids/21.4.977
  13. Challan AA, Gimotty PA, Geber LH, et al. Association between radiation field and does on wound complications following laryngectomy. Arch Otolaryngol Head Neck Surg 2004; 131:234
  14. Shih CC, Chen YC, Chang SC, Luh KT, Lee CY, Hsieh WC. Streptococcus pyogenes bacteremia-the impact of previous radiation and clindamycin resistance. Q J Med 1996;89: 369-375 https://doi.org/10.1093/qjmed/89.5.369
  15. Stevens DL. The toxic shock syndromes. Infect Dis Clin North Am 1996;10:727-746 https://doi.org/10.1016/S0891-5520(05)70324-X
  16. Reiss MA. Toxic shock syndrome. Pime Care Update Ob/ Gyns 2000;7:85-90 https://doi.org/10.1016/S1068-607X(00)00027-5
  17. Ramos-e-Silva M, Pereira ALC. Life-threatening eruptions due to infectious agents. Clin Dermatol 2005;23:148-156 https://doi.org/10.1016/j.clindermatol.2004.06.019
  18. Brown EJ. The molecular basis of streptococcal toxic shock syndrome. N Engl J Med 2004;350:2093-2094 https://doi.org/10.1056/NEJMcibr040657
  19. Toney JF, Parker MM. New perspectives on the management of septic shock in the cancer patient. Infect Dis Clin North Am 1996;10:239-248 https://doi.org/10.1016/S0891-5520(05)70298-1
  20. Darenberg J, Ihendyane N, Sjölin J, et al. Intravenous immunoglobulin G therapy in streptoccal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. CID 2003;37:333-340 https://doi.org/10.1086/376630